State of Wisconsin Investment Board
HRTX icon

State of Wisconsin Investment Board’s Heron Therapeutics HRTX Stock Holding History

State of Wisconsin Investment Board’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-23,177
Closed -$46.1K – 2311
2024
Q3 		$46.1K Sell
23,177
-119,825
-84% -$286K ﹤0.01% 2236
2024
Q2 		$501K Buy
+143,002
New +$439K ﹤0.01% 1822
2023
Q2 		– Sell
-15,022
Closed -$22.7K – 2426
2023
Q1 		$22.7K Sell
15,022
-3,494
-19% -$8.75K ﹤0.01% 2490
2022
Q4 		$46.3K Sell
18,516
-283,212
-94% -$912K ﹤0.01% 2404
2022
Q3 		$1.27M Buy
301,728
+18,274
+6% +$71.5K ﹤0.01% 1456
2022
Q2 		$791K Buy
283,454
+69,654
+33% +$280K ﹤0.01% 1801
2022
Q1 		$1.22M Buy
213,800
+95,900
+81% +$702K ﹤0.01% 1600
2021
Q4 		$1.08M Hold
117,900
– – ﹤0.01% 1430
2021
Q3 		$1.26M Hold
117,900
– – ﹤0.01% 1382
2021
Q2 		$1.83M Hold
117,900
– – ﹤0.01% 1311
2021
Q1 		$1.91M Sell
117,900
-6,700
-5% -$119K ﹤0.01% 1245
2020
Q4 		$2.64M Sell
124,600
-15,500
-11% -$269K 0.01% 1146
2020
Q3 		$2.08M Sell
140,100
-4,700
-3% -$73.3K 0.01% 1158
2020
Q2 		$2.13M Buy
144,800
+15,200
+12% +$250K 0.01% 1111
2020
Q1 		$1.52M Buy
129,600
+19,300
+17% +$363K 0.01% 1126
2019
Q4 		$2.59M Hold
110,300
– – 0.01% 1097
2019
Q3 		$2.04M Buy
110,300
+10,200
+10% +$188K 0.01% 1017
2019
Q2 		$1.86M Buy
100,100
+5,900
+6% +$118K 0.01% 1030
2019
Q1 		$2.3M Buy
94,200
+23,500
+33% +$615K 0.01% 975
2018
Q4 		$1.83M Buy
70,700
+4,500
+7% +$124K 0.01% 988
2018
Q3 		$2.1M Hold
66,200
– – 0.01% 1036
2018
Q2 		$2.57M Buy
66,200
+11,200
+20% +$357K 0.01% 960
2018
Q1 		$1.52M Buy
55,000
+22,000
+67% +$499K ﹤0.01% 1018
2017
Q4 		$597K Hold
33,000
– – ﹤0.01% 1264
2017
Q3 		$533K Hold
33,000
– – ﹤0.01% 1279
2017
Q2 		$457K Buy
+33,000
New +$478K ﹤0.01% 1305

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State of Wisconsin Investment Board's HRTX Position: Q4 2024 in Review

State of Wisconsin Investment Board sold out of Heron Therapeutics (HRTX) in Q4 2024, closing a stake of 23,177 shares — an estimated $46.1K sold.

State of Wisconsin Investment Board first reported a position in HRTX in Q2 2017 and held it in 26 quarters. The position peaked at $2.64M in Q4 2020. 161 funds tracked by Wall St. Rank hold HRTX as of Q4 2024.

  • State of Wisconsin Investment Board reported no remaining Heron Therapeutics position as of Q4 2024 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 23,177 Heron Therapeutics shares in Q4 2024, an estimated $46.1K.
  • State of Wisconsin Investment Board first reported a position in Heron Therapeutics in Q2 2017 and held it in 26 quarters.
  • State of Wisconsin Investment Board's Heron Therapeutics position peaked at $2.64M in Q4 2020.
  • 161 funds tracked by Wall St. Rank held Heron Therapeutics as of Q4 2024.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2024, filed 14 Feb 2025.